A patient with a second-degree AV block, Mobitz Type II, and bradycardia is being monitored in the cardiac unit. The nurse notes that the patient is experiencing dizziness and fatigue. Which of the following interventions should the nurse prioritize to prevent further complications?

B) Prepare the patient for temporary transvenous pacemaker insertion

A) Administer a beta-blocker to manage the bradycardia

B) Prepare the patient for temporary transvenous pacemaker insertion

C) Increase the dose of Lisinopril to improve cardiac function

D) Encourage the patient to ambulate frequently to improve circulation

A patient with a second-degree AV block, Mobitz Type II, and bradycardia is admitted for close monitoring. The healthcare team is considering the use of a temporary transvenous pacemaker. Which nursing action is most appropriate to prioritize while the patient is awaiting this intervention?

C) Monitor the patient's ECG and report any change in rhythm to the healthcare provider immediately

A) Administer supplemental oxygen to maintain oxygen saturation above 95%

B) Encourage the patient to ambulate frequently to prevent venous stasis

C) Monitor the patient's ECG and report any change in rhythm to the healthcare provider immediately

D) Increase oral fluid intake to ensure adequate hydration

A patient with bradycardia and frequent episodes of dizziness has received a temporary transvenous pacemaker. After stabilization, the patient's potassium level is noted to be 5.0 mmol/L. What is the most appropriate nursing action based on this information?

A) Continue monitoring the patient and report any changes in symptoms.

B) Immediately consult with cardiology for the insertion of a permanent pacemaker.

C) Administer potassium supplements to maintain electrolyte balance.

D) Discontinue the temporary pacemaker to assess if the heart rate is stabilized.

A patient admitted with bradycardia due to frequent dropped QRS complexes is now experiencing dizziness and near-syncope. After the insertion of a temporary transvenous pacemaker, symptoms improved. What is the priority nursing intervention following the pacemaker insertion to ensure patient safety?

A) Monitor for signs of infection at the insertion site

B) Assess the patient's electrolyte levels daily

C) Educate the patient on activity restrictions

D) Regularly check the pacemaker's battery function

A patient with mild left ventricular hypertrophy and frequent premature ventricular contractions (PVCs) is experiencing episodes of hypotension when transitioning from a supine to an upright position. Which nursing intervention should be prioritized to prevent further hemodynamic instability?

B) Encourage the patient to change positions slowly and dangle legs before standing.

A) Increase the patient's fluid intake to maintain blood pressure.

B) Encourage the patient to change positions slowly and dangle legs before standing.

C) Administer antiarrhythmic medication to decrease the frequency of PVCs.

D) Adjust the temporary pacemaker settings to improve heart rate regulation.

A patient with mild left ventricular hypertrophy and frequent premature ventricular contractions (PVCs) is experiencing fluctuating blood pressure with episodes of hypotension upon position changes. Which nursing intervention is the most appropriate to address the risk of hemodynamic instability in this patient?

C) Educate the patient on slow position changes to minimize orthostatic hypotension

A) Encourage the patient to increase oral fluid intake to enhance blood volume

B) Administer prescribed beta-blockers to control PVCs and stabilize blood pressure

C) Educate the patient on slow position changes to minimize orthostatic hypotension

D) Recommend a low-sodium diet to manage hypertension and reduce cardiac workload

A patient with worsening orthostatic hypotension and increased premature ventricular contractions (PVCs) is being monitored. After reducing the dose of antihypertensive medications and administering intravenous fluids, the patient reports palpitations and 'fluttering' in the chest. Which nursing intervention is most appropriate at this time to address these symptoms and prevent complications?

C) Notify the healthcare provider about the new onset of symptoms and potential arrhythmic changes.

A) Increase the rate of intravenous fluid administration to stabilize blood pressure.

B) Encourage the patient to perform Valsalva maneuvers to reduce palpitations.

C) Notify the healthcare provider about the new onset of symptoms and potential arrhythmic changes.

D) Advise the patient to lie flat in bed to minimize dizziness and lightheadedness.

A patient with a history of orthostatic hypotension and increased frequency of premature ventricular contractions (PVCs) is experiencing dizziness and lightheadedness upon standing. After adjusting his medication regimen and administering IV fluids, he reports new-onset palpitations and 'fluttering' in the chest. Which nursing intervention is most appropriate to address the patient's current symptoms and prevent further complications?

C) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

A) Educate the patient on performing the Valsalva maneuver to manage palpitations.

B) Encourage the patient to increase fluid intake to maintain blood pressure and electrolyte balance.

C) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

D) Administer antiarrhythmic medications as prescribed to manage the PVCs and palpitations.

A patient with a newly diagnosed type II second-degree AV block and multifocal premature ventricular contractions is scheduled for a dual-chamber pacemaker implantation. The patient now presents with mild peripheral edema and shortness of breath, and an echocardiogram reveals mildly reduced left ventricular ejection fraction. Which nursing intervention is most critical at this time?

B) Monitor the patient's electrolyte levels closely and prepare for diuretic therapy.

A) Encourage the patient to increase fluid intake to improve renal perfusion.

B) Monitor the patient's electrolyte levels closely and prepare for diuretic therapy.

C) Advise the patient to limit physical activity until the pacemaker is implanted.

D) Educate the patient on the benefits of a low-sodium diet to manage symptoms.

A patient with a newly diagnosed type II second-degree AV block and multifocal premature ventricular contractions is scheduled for a dual-chamber pacemaker implantation. The patient is also on amiodarone therapy. Which nursing intervention is most important to perform prior to the procedure?

D) Check the patient's electrolyte levels and report any abnormalities.

A) Educate the patient about lifestyle changes post-implantation.

B) Monitor the patient for signs of hyperthyroidism.

C) Ensure the patient has remained NPO (nothing by mouth) as ordered.

D) Check the patient's electrolyte levels and report any abnormalities.

heart blocks - Nursing Case Study

Pathophysiology

• Primary mechanism: Heart blocks primarily occur due to disrupted electrical conduction within the heart, often at the atrioventricular (AV) node. This disruption can be caused by fibrosis, ischemia, or medications that alter the conduction pathway, leading to delayed or blocked impulses between atria and ventricles.

• Secondary mechanism: Structural damage or remodeling of cardiac tissue, often from conditions like myocardial infarction or cardiomyopathy, can further contribute to impaired conduction. This results in inconsistent transmission of electrical signals, causing irregular heart rhythms.

• Key complication: Heart blocks can lead to decreased cardiac output and inadequate perfusion of vital organs, potentially causing symptoms like dizziness, syncope, or heart failure in severe cases. Early identification and management are crucial to prevent progression.

Patient Profile

Demographics:

62-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Hyperlipidemia

• Current medications: Metformin 500 mg BID, Lisinopril 20 mg daily, Atorvastatin 40 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Episodes of dizziness and fatigue

• Key symptoms: Palpitations, shortness of breath, occasional chest discomfort

• Vital signs: Blood pressure 145/90 mmHg, heart rate 50 bpm, respiratory rate 18 breaths per minute, oxygen saturation 95% on room air, temperature 98.6°F

Section 1

During the initial assessment, the healthcare team conducted a thorough cardiovascular examination and an electrocardiogram (ECG) to evaluate the suspected heart block. The ECG revealed a second-degree AV block, Mobitz Type II, characterized by a consistent P wave pattern with intermittent non-conducted P waves, leading to dropped QRS complexes. This pattern indicates a more serious condition with a higher risk of progression to complete heart block. The patient's heart rate remained bradycardic at 50 bpm, contributing to his symptoms of dizziness and fatigue. Auscultation of the heart noted an irregular rhythm consistent with the ECG findings.

In addition to the ECG findings, laboratory tests were ordered to assess the patient's electrolyte levels, renal function, and cardiac enzymes. The lab results showed slightly elevated potassium levels at 5.2 mmol/L, which could exacerbate the conduction abnormalities. Renal function tests were within normal limits, ruling out acute kidney injury as a contributing factor. Cardiac enzymes were not elevated, suggesting that myocardial infarction was not the immediate cause of the patient's symptoms.

Given these findings, the healthcare team decided to admit the patient for close monitoring and further evaluation of his cardiac status. A temporary transvenous pacemaker was considered to manage the bradycardia and prevent progression to complete heart block. The plan included adjusting medications that could affect conduction, such as reducing or holding the dose of Lisinopril, and consulting cardiology for potential permanent pacemaker placement if indicated. These steps were crucial in stabilizing the patient and preventing further complications, such as syncope or worsening heart failure, while planning for long-term management options.

Section 2

Shortly after admission, the patient's condition began to show some changes. During routine monitoring, the healthcare team observed an increase in the frequency of dropped QRS complexes, resulting in more pronounced bradycardia. His heart rate decreased further to 45 bpm, and he began experiencing more frequent episodes of dizziness and near-syncope, indicating a possible progression toward complete heart block. The irregular rhythm continued to be evident on auscultation, and telemetry showed an increase in the number of non-conducted P waves, heightening concerns about the stability of his cardiac conduction system.

In response to these changes, the decision was made to implement a temporary transvenous pacemaker. This intervention aimed to stabilize his heart rate and prevent further bradycardic episodes. The insertion of the pacemaker was uneventful, and initial settings were adjusted to maintain a heart rate of 60 bpm. Following pacemaker placement, the patient's symptoms showed some improvement, with a reduction in dizziness and no further episodes of near-syncope. However, the team remained vigilant for any signs of infection or complications related to the pacemaker, such as lead displacement or thrombosis.

Simultaneously, a repeat set of laboratory tests was conducted to reassess electrolyte balance and cardiac status. Notably, the patient's potassium level had decreased slightly to 5.0 mmol/L, likely due to dietary adjustments and intravenous fluids. This modest improvement suggested that electrolyte abnormalities were being addressed effectively. Despite these positive changes, the healthcare team decided that a consultation with cardiology was essential to discuss the potential need for a permanent pacemaker. This decision would depend on the patient's overall response to the temporary pacemaker and the likelihood of recurrent heart block episodes in the absence of the device.

Section 3

As the healthcare team continued to monitor the patient closely, new diagnostic results revealed additional insights into his cardiac condition. A follow-up echocardiogram was performed to evaluate the structural integrity and function of the heart. The echocardiogram showed mild left ventricular hypertrophy, which could be contributing to the conduction disturbances but no significant valvular abnormalities or signs of ischemia were noted. Meanwhile, telemetry data over the next 24 hours indicated occasional premature ventricular contractions (PVCs) that were becoming increasingly frequent. This raised concerns about the potential for developing more complex arrhythmias that could further compromise the patient's cardiac stability.

In addition to the echocardiogram findings, laboratory tests showed a slight increase in cardiac biomarkers, with a troponin level of 0.04 ng/mL, which remained within normal limits but was slightly higher than previous measurements. This subtle rise prompted a re-evaluation of the patient's ischemic risk factors, including his history of hypertension and hyperlipidemia. Moreover, the patient's blood pressure readings were fluctuating, with episodes of hypotension, particularly when transitioning from a supine to an upright position. These findings suggested a need for careful optimization of the patient's fluid status and medication regimen to prevent further hemodynamic instability.

Despite the initial stabilization with the temporary pacemaker, the patient reported experiencing mild chest discomfort, prompting the team to explore potential causes. Given these developments, the cardiology team recommended an adjustment of the pacemaker settings to address the PVCs and further stabilize the heart rhythm. At the same time, discussions about the potential benefits and timing of a permanent pacemaker implantation were accelerated, with plans for a more comprehensive electrophysiological evaluation. The team also reinforced the importance of ongoing monitoring for any signs of infection or complications related to the temporary pacemaker, as well as the continued reassessment of electrolyte and fluid balance in managing the patient's evolving condition.

Section 4

As the healthcare team continued to closely monitor the patient, a change in his status became evident over the next 48 hours. The patient began experiencing increased episodes of dizziness and lightheadedness, particularly when attempting to stand or walk, suggesting a worsening of his orthostatic hypotension. His blood pressure readings became more erratic, with systolic values occasionally dropping to as low as 85 mmHg during positional changes. Concurrently, the frequency of premature ventricular contractions (PVCs) increased, with some episodes lasting longer, indicative of a potential transition towards more sustained ventricular arrhythmias.

In response to these developments, the team adjusted the patient's medication regimen by reducing the dose of his antihypertensive medications to mitigate the risk of further hypotensive episodes. Additionally, intravenous fluids were carefully titrated to maintain optimal hydration and support blood pressure stability without overloading the cardiovascular system. However, despite these interventions, the patient reported a new onset of palpitations and an intermittent sensation of "fluttering" in his chest, raising concerns about the potential evolution of his arrhythmias.

To further elucidate the underlying cause of these changes, the cardiology team expedited a comprehensive electrophysiological study. This procedure aimed to assess the electrical pathways within the heart more precisely and determine the necessity for a permanent pacemaker or additional antiarrhythmic therapy. Meanwhile, continuous telemetry remained crucial to detect any progression to more complex arrhythmias, such as ventricular tachycardia, that could compromise the patient's condition. The healthcare team also emphasized vigilant monitoring for signs of infection related to the temporary pacemaker, as well as frequent reassessment of electrolyte levels, particularly potassium and magnesium, given their critical role in cardiac conduction and rhythm stability. As the patient's clinical picture evolved, these findings and interventions set the stage for a thoughtful consideration of the next steps in his cardiac care journey.

Section 5

As the healthcare team continued their diligent observation, the results of the comprehensive electrophysiological study revealed critical insights into the patient's cardiac condition. The study identified a type II second-degree atrioventricular (AV) block, elucidating the cause of the patient's increasing dizziness and palpitations. This finding indicated an intermittent failure of electrical impulses to traverse the AV node, leading to missed heartbeats and contributing to the patient's erratic blood pressure and orthostatic symptoms. Furthermore, the study confirmed the presence of multifocal premature ventricular contractions, with occasional brief runs of non-sustained ventricular tachycardia, underscoring the need for immediate intervention to prevent more severe arrhythmias.

In response to these diagnostic results, the cardiology team recommended the urgent implantation of a dual-chamber pacemaker to ensure reliable ventricular pacing and prevent further episodes of hemodynamic instability. This decision was informed by the patient's persistent symptoms and the electrophysiological findings that indicated a high risk of progression to complete heart block. Concurrently, the team initiated an antiarrhythmic medication, amiodarone, to address the increased ventricular ectopy and reduce the risk of sustained ventricular tachycardia, guided by the patient's renal and hepatic function tests, which were within normal ranges.

Despite these interventions, new complications emerged. The patient developed mild peripheral edema and shortness of breath, raising concerns about potential fluid overload or heart failure exacerbation. A repeat echocardiogram revealed mildly reduced left ventricular ejection fraction, suggesting a decrease in cardiac function possibly related to the arrhythmias. These developments prompted the healthcare team to adjust the intravenous fluid regimen and initiate low-dose diuretics while maintaining close monitoring of the patient's electrolyte balance. Through these concerted efforts, the team aimed to stabilize the patient's condition while preparing for the pacemaker implantation, ensuring a comprehensive and adaptive approach to his evolving cardiac care needs.